Altimmune, Inc. (ALT)
3.625
+0.12
(+3.57%)
USD |
NASDAQ |
Mar 16, 16:00
3.68
+0.06
(+1.52%)
After-Hours: 18:21
Altimmune Market Cap : 453.96M for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 882.85B |
| CorMedix, Inc. | 517.78M |
| Amgen, Inc. | 197.46B |
| Viking Therapeutics, Inc. | 4.159B |
| Verastem, Inc. | 435.35M |
Market Cap Related Metrics
| PS Ratio | 7671.22 |
| Price to Book Value | 2.019 |
| Price | 3.625 |
| Earnings Yield | -28.01% |